Holen Sie sich die Stockscreener-App
34.20
0.38%
0.06
Schlusskurs vom Vortag:
$34.14
Offen:
$34.1
24-Stunden-Volumen:
254.08K
Relative Volume:
0.44
Marktkapitalisierung:
$1.74B
Einnahmen:
$276.26M
Nettoeinkommen (Verlust:
$16.52M
KGV:
111.11
EPS:
0.3078
Netto-Cashflow:
$24.75M
1W Leistung:
+12.18%
1M Leistung:
+1.66%
6M Leistung:
+1.57%
1J Leistung:
-18.25%
1-Tages-Spanne:
$33.47
$34.63
1-Wochen-Bereich:
$31.06
$35.20
52-Wochen-Spanne:
$28.95
$45.97
Vericel Corp Stock (VCEL) Company Profile
Firmenname
Vericel Corp
Sektor
Branche
Telefon
(734) 930-5555
Adresse
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
34.19 | 1.74B | 276.26M | 16.52M | 24.75M | 0.3078 |
VRTX
Vertex Pharmaceuticals Inc
|
433.53 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.09 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.05 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.95 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.57 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-06-20 | Eingeleitet | TD Cowen | Buy |
| 2024-01-25 | Hochstufung | Truist | Hold → Buy |
| 2023-08-08 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-11-09 | Herabstufung | Truist | Buy → Hold |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2021-01-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Eingeleitet | Stephens | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2019-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Needham | Buy → Hold |
| 2018-08-08 | Bestätigt | Needham | Buy |
| 2018-07-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Eingeleitet | Leerink Partners | Outperform |
| 2018-03-06 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2018-03-05 | Bestätigt | BTIG Research | Buy |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-03-13 | Bestätigt | Needham | Buy |
| 2016-12-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-09 | Bestätigt | Needham | Buy |
| 2016-04-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Vericel Corp Aktie (VCEL) Neueste Nachrichten
Aberdeen Group plc Has $21.03 Million Stock Position in Vericel Corporation $VCEL - MarketBeat
Analysts Set Vericel Corporation (NASDAQ:VCEL) Price Target at $56.00 - Defense World
Vericel Corporation (VCEL) Stock forecasts - Yahoo Finance UK
VCEL SEC FilingsVericel 10-K, 10-Q, 8-K Forms - Stock Titan
Allspring Global Investments Holdings LLC Cuts Position in Vericel Corporation $VCEL - MarketBeat
Vericel Corporation (VCEL) Stock Forecasts - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com India
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com
Vericel (VCEL) Secures Lucrative Contract with Health and Human Services - gurufocus.com
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
U.S. burn emergency stockpile gets NexoBrid in $197M BARDA pact - Stock Titan
[144] Vericel Corp SEC Filing - Stock Titan
Soleus discloses 2.55M Vericel shares (NASDAQ: VCEL) - Stock Titan
Vericel Corp (VCEL) Stock Price Quote Today & Current Price Chart - Capital.com
Vericel Corp (VCEL) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Quarterly Trades: Is Vericel Corporation in a bullish channel2026 Market Mood & Free Verified High Yield Trade Plans - baoquankhu1.vn
Market Wrap: Is Vericel Corporation stock forming a triangle pattern2026 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Vericel stock hits 52-week low at 29.21 USD By Investing.com - Investing.com Australia
Vericel (NASDAQ:VCEL) Stock Rating Upgraded by Wall Street Zen - MarketBeat
[Form 4] Vericel Corp Insider Trading Activity - stocktitan.net
Vericel (NASDAQ:VCEL) Hits New 52-Week LowWhat's Next? - MarketBeat
Vanguard disaggregates holdings; files 13G/A for Vericel (VCEL) - Stock Titan
Vericel stock hits 52-week low at 29.21 USD - Investing.com
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick - ChartMill
Vericel (NASDAQ:VCEL) Stock Price Down 4.9%Time to Sell? - marketbeat.com
Vericel corp director Hagen sells $486k in shares By Investing.com - Investing.com India
Vericel corp director Hagen sells $486k in shares - Investing.com
Vericel (VCEL) director sells 15,000 shares after option exercise - Stock Titan
Vericel Corporation $VCEL Position Increased by Congress Asset Management Co. - marketbeat.com
Vericel Corp ($VCEL) CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] Vericel Corp SEC Filing - Stock Titan
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
What Makes Vericel Corporation (VCEL) an Investment Bet? - Yahoo Finance
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart
Dilated Cardiomyopathy Market: Rapid Growth & Investment - openPR.com
Bank Watch: Can Vericel Corporation sustain earnings growth2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion By Investing.com - Investing.com Australia
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion - Investing.com South Africa
Leerink reiterates Outperform on Vericel stock, $46 target - Investing.com
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - Yahoo Finance
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI - Finviz
Vericel (VCEL) Valuation In Focus After FDA Clears MACI Commercial Manufacturing Capacity - simplywall.st
Vericel (NASDAQ:VCEL) Downgraded by Wall Street Zen to Hold - MarketBeat
Vericel (VCEL) Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed? - simplywall.st
Vericel wins FDA approval for MACI production at new facility - Investing.com
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel wins FDA approval for MACI production at new facility By Investing.com - Investing.com Canada
Vericel (VCEL) COO sells 10,305 shares in automatic Rule 10b5-1 trade - Stock Titan
Finanzdaten der Vericel Corp-Aktie (VCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vericel Corp-Aktie (VCEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rubino Alan L | Director |
Mar 25 '26 |
Option Exercise |
2.76 |
15,000 |
41,400 |
60,994 |
| Hagen Heidi | Director |
Mar 23 '26 |
Option Exercise |
2.76 |
15,000 |
41,400 |
46,850 |
| Hagen Heidi | Director |
Mar 23 '26 |
Sale |
32.41 |
15,000 |
486,150 |
31,850 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):